Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Aug;18(8):979-84.
doi: 10.1007/s00520-010-0856-3. Epub 2010 Mar 20.

Systematic reviews of oral complications from cancer therapies, Oral Care Study Group, MASCC/ISOO: methodology and quality of the literature

Affiliations
Review

Systematic reviews of oral complications from cancer therapies, Oral Care Study Group, MASCC/ISOO: methodology and quality of the literature

Michael T Brennan et al. Support Care Cancer. 2010 Aug.

Abstract

Background: Oral complications are commonly experienced by patients undergoing cancer therapies. The Oral Care Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) has completed nine systematic reviews including Bisphosphonate Osteonecrosis of the Jaw, Odontogenic/Periodontal Infection, Dysgeusia, Oral Fungal Infection, Osteoradionecrosis, Trismus, Oral Pain, Oral Viral Infection, and Xerostomia.

Methods: The aims of these reviews were to determine the prevalence of each oral complication, relationship with quality of life, economic impact, and formulation of guidelines based on the quality of the literature. The present article described the details of the methodology and statistical analysis utilized in these nine systematic reviews. Additionally, a summary of the quality of the literature from these oral complications is presented.

Conclusion: Oral complications associated with cancer therapies are common among cancer patients. The systematic reviews by the Oral Care Study Group of MASCC/ISOO provide a thorough assessment of the available literature for these oral complications.

PubMed Disclaimer

References

    1. J Clin Epidemiol. 1998 Oct;51(10):801-7 - PubMed
    1. Med J Aust. 1992 Nov 2;157(9):603-11 - PubMed
    1. NCI Monogr. 1990;(9):11-5 - PubMed
    1. NCI Monogr. 1990;(9):1-184 - PubMed
    1. Cancer. 2004 May 1;100(9 Suppl):2026-46 - PubMed

LinkOut - more resources